{"title":"在怀孕期间害怕使用药物会危及妇女和儿童的生命。","authors":"Christine Ekechi","doi":"10.12968/hmed.2022.0312","DOIUrl":null,"url":null,"abstract":"<p><p>Medicine research and development has been instrumental in improving outcomes for countless individuals, but women, especially pregnant women, have been left behind. Disadvantaged during pregnancy as a result of apprehension over drug use for new or existing conditions, women face worse outcomes for under- or untreated disease. Solving this problem will require input from regulators, the pharmaceutical industry and clinicians.</p>","PeriodicalId":520576,"journal":{"name":"British journal of hospital medicine (London, England : 2005)","volume":" ","pages":"1-3"},"PeriodicalIF":1.8000,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fear of using medicines in pregnancy risks the lives of women and children.\",\"authors\":\"Christine Ekechi\",\"doi\":\"10.12968/hmed.2022.0312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Medicine research and development has been instrumental in improving outcomes for countless individuals, but women, especially pregnant women, have been left behind. Disadvantaged during pregnancy as a result of apprehension over drug use for new or existing conditions, women face worse outcomes for under- or untreated disease. Solving this problem will require input from regulators, the pharmaceutical industry and clinicians.</p>\",\"PeriodicalId\":520576,\"journal\":{\"name\":\"British journal of hospital medicine (London, England : 2005)\",\"volume\":\" \",\"pages\":\"1-3\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British journal of hospital medicine (London, England : 2005)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12968/hmed.2022.0312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/11/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of hospital medicine (London, England : 2005)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12968/hmed.2022.0312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/11/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Fear of using medicines in pregnancy risks the lives of women and children.
Medicine research and development has been instrumental in improving outcomes for countless individuals, but women, especially pregnant women, have been left behind. Disadvantaged during pregnancy as a result of apprehension over drug use for new or existing conditions, women face worse outcomes for under- or untreated disease. Solving this problem will require input from regulators, the pharmaceutical industry and clinicians.